Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

aMVAC.P_005_TURBT_S223

7e22eaf7-5f13-5e90-9f8e-b57eb17d1cc8

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • KRAS_SIGNALING_DN+0.250
  • SPERMATOGENESIS+0.150
  • PANCREAS_BETA_CELLS+0.140
  • BILE_ACID_METABOLISM+0.040
  • XENOBIOTIC_METABOLISM+0.000
  • MYOGENESIS-0.030
  • MYC_TARGETS_V2-0.140
  • HEME_METABOLISM-0.160
  • FATTY_ACID_METABOLISM-0.180
  • COAGULATION-0.190

Top 10 suppressed

  • INTERFERON_GAMMA_RESPONSE-0.600
  • INTERFERON_ALPHA_RESPONSE-0.580
  • TGF_BETA_SIGNALING-0.570
  • TNFA_SIGNALING_VIA_NFKB-0.540
  • ALLOGRAFT_REJECTION-0.510
  • ANDROGEN_RESPONSE-0.510
  • INFLAMMATORY_RESPONSE-0.500
  • PROTEIN_SECRETION-0.500
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.490
  • G2M_CHECKPOINT-0.490

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

9 twins match this tumor's tissue · 1 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1TCGA-E7-A7PW-01A-11R-A352-07
bladder-landscape@3
0.954
2SRR1797247
lung-landscapes@6
cohortSC0.953
3SRR8943038
bladder-landscape@3
0.952
4SRR1797231
lung-landscapes@6
cohortSC0.944
5SRR25617918
breast-umap@18
B0.942
6SRR23303752
bladder-landscape@3
0.941
7SRR1516072
bladder-landscape@3
0.939
8SRR1467813
brain-umap@2
GTEX0.937
9TCGA-E9-A245-01A-22R-A16F-07
breast-umap@18
B0.934
10SRR12202498
bladder-landscape@3
0.934

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 4 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
KRAS_SIGNALING_DN0.250Remibrutinib— uncovered
SPERMATOGENESIS0.150Inavolisib— uncovered
PANCREAS_BETA_CELLS0.140Cobimetinib— uncovered
BILE_ACID_METABOLISM0.040Inavolisib— uncovered